The 13th Annual UBS Global Life Sciences Conference will be held at the Grand Hyatt New York, Monday, September 19 -

--(BUSINESS WIRE)-- UBS (NYSE: UBS):

WHAT:

  UBS’s Annual Global Life Sciences Conference, one of the industry’s largest, will feature presentations from executives of approximately 270 companies in the following life sciences sectors: Biotechnology, Life Sciences Tools, Medical Technology, Pharmaceuticals and Specialty Pharmaceuticals.
 

As part of this year’s agenda, the conference will also feature an informative and lively keynote discussion with:

 

-- Senator Bill Frist, Former Majority Leader, United States Senate

-- Governor Howard Dean, Former Governor of Vermont and Former Chair of the Democratic National Committee

 

Presenting Companies include:

 
Acorda Therapeutics   Agilent Technologies, Inc.   Alexion Pharmaceuticals, Inc
Algeta ASA Alkermes Allergan, Inc.
Amarin Amgen, Inc. ArthroCare
Baxter Bayer AG Biogen Idec
BioMarin Pharmaceutical, Inc. Bio-Rad Laboratories, Inc. Bruker Corporation
BTG plc Celgene Corporation Cepheid
Coloplast A/S Cubist Pharmaceuticals DENTSPLY International
Endo Pharmaceuticals Exelixis Gilead Sciences, Inc.
Glenmark Generics Ltd. Grünenthal Group H. Lundbeck A/S
Haemonetics Corporation Healthpoint Biotherapeutics Human Genome Sciences, Inc.
Illumina, Inc. Impax Laboratories Incyte Corp.
Intuitive Surgical Ion Beam Applications SA Jazz Pharmaceuticals, Inc.
Life Technologies Medicis Pharmaceutical Corporation Meridian Bioscience, Inc.
Mettler-Toledo International, Inc. Mylan, Inc. Novo Nordisk, Inc.
NxStage Medical, Inc. Onyx Pharmaceuticals Pall Corporation
Par Pharmaceutical PerkinElmer, Inc. Pharmasset
Questcor Pharmaceuticals, Inc. QIAGEN N.V. Regeneron Pharmaceuticals, Inc.
ResMed Seattle Genetics, Inc. Shanghai Fosun Pharma Group
Shangpharma Sigma-Aldrich Corporation Sirona Dental Systems, Inc.
SkinMedica Teva Pharmaceutical Industries Ltd. Thermo Fisher Scientific
United Therapeutics Corporation Valeant Pharmaceuticals Vertex Pharmaceuticals
Warner Chilcott West Pharmaceutical Services, Inc. ZOLL Medical Corporation
 

*This is a partial list of presenting companies. Companies subject to change. To access the agenda, please go to www.ibb.ubs.com/Conferences.

AUDIO

 

WEBCAST:

Audio transmissions and the conference agenda will be available on the UBS Investment Bank website at www.ibb.ubs.com/Conferences. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for up to four weeks.

 

REGISTER:

Members of the media may register for the conference by contacting Torie von Alt at [email protected] or (212) 713-3262.



CONTACT:

UBS
Torie von Alt, 212-713-3262
[email protected]

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical  Professional Services  Banking  Finance  Other Science  Science

MEDIA:

Logo
 Logo

Suggested Articles

AbbVie and Allergan were already jumping through hoops for their merger before a new tax added hundreds of millions to the cost.

Avastin and Herceptin saw U.S. slowdown that's “not very pronounced” after bioisim launched, but Roche execs still warn of "a significant impact.…

Novo Nordisk, which recently completed a wastewater treatment plant for its massive U.S. API site, has made a gift of the $40 million facility.